Redcare Pharmacy rises on 'good' Q3 margin, confirmed outlook

Redcare Pharmacy NV

06/10/2025 07:52

** Shares in Redcare Pharmacy RDC.DE rise around 6% in early Frankfurt trade, with a local trader pointing to the German online drug retailer reporting a "good" margin and confirming its outlook

** Q3 sales came in at 719 million euros ($842.02 million), up 25% y/y

** CEO Olaf Heinrich said the company delivered a solid Q3 EBITDA, lifting its year-to-date margin to its full-year guidance range of 2-2.5%; Redcare Pharmacy will report full Q3 results on October 29

** "Market was aware of declining growth rates in Q325, thus no more shocker. Good margin and confirmed FY25 outlook should help shares," the trader writes

** The stock is at the top of Germany's mid-cap index .MDAXI in early Frankfurt trade

($1 = 0.8539 euros)

(Reporting by Tristan Veyet)

((Tristan.chabba@thomsonreuters.com))